Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Bharat Biotech in-licences GSK's Shigella vaccine candidate

Δημοσιευμένα

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!

Sports

'Means a lot': Pant wins hearts, funds college admission for a student

Rishabh Pant demonstrated his compassionate side by assisting Jyoti Kanaboor Math, a bright...

από 0 0

Sports

Chennai Grand Masters: Arjun Erigaisi’s chance to turn around indifferent year

Arjun Erigaisi seeks to regain his form at the Chennai Grand Masters after a series of...

από 0 0

Sports

Chennai Grand Masters: With daughter in tow, ‘guilt’-free Harika takes on the best

D Harika, India's No. 2 female Grandmaster, balances her chess career with motherhood, finding...

από 0 0

International

Elon Musk’s ‘Five Things’ email program shut down by Trump administration: What was the controversial project that sparked panic among federal employees?

The Trump administration has ended Elon Musk's unpopular "Five Things" email program, which...

από 0 4

National

Gold price falls slightly while silver inches up

KATHMANDU: The price of gold in the Nepali market dropped slightly on Wednesday, declining by Rs...

από 0 14